Optimizing IBS Management through Accurate Disease Assessment and Improved Treatment Selection (ID: i740a) Survey

Question Title

* 1. How many patients with IBS do you currently manage in your practice? Please respond with your best approximate number.

Question Title

* 2. How many years have you been in practice?

1-10

11-20

≥21

Question Title

* 3. Jane is a 32-year-old female diagnosed with IBS-D. Jane’s symptoms include loose, watery stool, bloating, and lower abdominal pain. Based on her symptoms, which of the following class(es) of therapy would you recommend for Jane? Please select all that apply.

Probiotics

5-HT3 antagonists

Antidepressants

Antibiotics

Mu-opioid agonists/delta-opioid antagonists

Question Title

* 4. Which of the following best describes the impact of this activity on your performance?

I gained new strategies/skills/information that I can apply to my area of practice.

I need more information before I change my practice behavior.

This activity will not change my practice, as my current practice is consistent with the information presented.

This activity will not change my practice, as I do not agree with the information presented.

Question Title

* 5. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes.

Question Title

* 6. As a result of your participation in this activity, what strategies/changes do you plan to implement in your practice?

Question Title

* 7. What barriers do you see to making changes in your practice?

Question Title

* 8. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities:

Question Title

* 9. After participating in today’s activity, I am now able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Apply an approach to the diagnosis of IBS that is consistent with current evidence-based guidelines	Apply an approach to the diagnosis of IBS that is consistent with current evidence-based guidelines Strongly agree	Apply an approach to the diagnosis of IBS that is consistent with current evidence-based guidelines Agree	Apply an approach to the diagnosis of IBS that is consistent with current evidence-based guidelines Neutral	Apply an approach to the diagnosis of IBS that is consistent with current evidence-based guidelines Disagree	Apply an approach to the diagnosis of IBS that is consistent with current evidence-based guidelines Strongly disagree
Utilize best practices for the management of IBS, including accurate assessment of disease impact and selection of effective therapy	Utilize best practices for the management of IBS, including accurate assessment of disease impact and selection of effective therapy Strongly agree	Utilize best practices for the management of IBS, including accurate assessment of disease impact and selection of effective therapy Agree	Utilize best practices for the management of IBS, including accurate assessment of disease impact and selection of effective therapy Neutral	Utilize best practices for the management of IBS, including accurate assessment of disease impact and selection of effective therapy Disagree	Utilize best practices for the management of IBS, including accurate assessment of disease impact and selection of effective therapy Strongly disagree
Describe current evidence in support of the gut microbiota as a therapeutic target in IBS treatment	Describe current evidence in support of the gut microbiota as a therapeutic target in IBS treatment Strongly agree	Describe current evidence in support of the gut microbiota as a therapeutic target in IBS treatment Agree	Describe current evidence in support of the gut microbiota as a therapeutic target in IBS treatment Neutral	Describe current evidence in support of the gut microbiota as a therapeutic target in IBS treatment Disagree	Describe current evidence in support of the gut microbiota as a therapeutic target in IBS treatment Strongly disagree

Question Title

* 10. Brian E. Lacy, MD, PhD, effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the material	Presented the material Strongly agree	Presented the material Agree	Presented the material Neutral	Presented the material Disagree	Presented the material Strongly disagree
Avoided commercial bias	Avoided commercial bias Strongly agree	Avoided commercial bias Agree	Avoided commercial bias Neutral	Avoided commercial bias Disagree	Avoided commercial bias Strongly disagree

Question Title

* 11. The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Question Title

* 12. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 13. How would you rate the format of this activity?

Excellent

Average

Below average

Poor

Question Title

* 14. Would you be willing to participate in a post activity follow-up survey?

Yes